EDWARDS LIFESCIENCES CORPORATION Funds and ETFs Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.43 USD | -1.80% |
|
+0.57% | +13.35% |
| Apr. 26 | Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92 | MT |
| Apr. 26 | Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83 | MT |
ETFs positioned on Edwards Lifesciences Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.46% | 44 M€ | +0.64% | - | |
| 2.34% | 18 M€ | +3.79% | - | |
| 2.13% | 6 M€ | 0.00% | - | |
| 1.17% | 226 M€ | +2.03% | - | |
| 1.17% | 25 M€ | -1.22% | - | |
| 1.17% | 26 M€ | -1.25% | - | |
| 1.11% | 16 M€ | -8.49% | ||
| 1.06% | 2 M€ | +6.77% | ||
| 0.97% | 1 M€ | +2.21% | - | |
| 0.94% | 4,592 M€ | +11.18% | ||
| 0.89% | 40 M€ | -.--% | ||
| 0.73% | 9 M€ | -.--% | - | |
| 0.52% | 1 M€ | +16.32% | ||
| 0.46% | 2 M€ | +20.44% | - | |
| 0.44% | 5 M€ | -72.95% | - | |
| 0.42% | 3,859 M€ | +18.82% | - | |
| 0.42% | 469 M€ | -2.05% | - | |
| 0.36% | 8 M€ | +2.44% | ||
| 0.36% | 2,510 M€ | +12.00% | ||
| 0.34% | 36 M€ | -.--% | ||
| 0.33% | 52 M€ | +6.98% | ||
| 0.33% | 26 M€ | +2.00% | - | |
| 0.30% | 717 M€ | +6.20% | ||
| 0.30% | 219 M€ | +17.17% | - | |
| 0.30% | 1,448 M€ | -.--% | - | |
| 0.25% | 277 M€ | -.--% | - | |
| 0.24% | 194 M€ | +7.48% | - | |
| 0.24% | 441 M€ | +10.26% | ||
| 0.24% | 330 M€ | -.--% | - | |
| 0.23% | 2 M€ | +14.69% | - | |
| 0.23% | 9 M€ | +2.75% | - | |
| 0.23% | 736 M€ | +6.09% | ||
| 0.21% | 276 M€ | +11.40% | - |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-05-07
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
86.43
USD
Average target price
94.63
USD
Spread / Average Target
+9.48%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +13.35% | 52.02B | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B | |
| +26.76% | 32.03B |
- Stock Market
- Equities
- EW Stock
- Funds and ETFs Edwards Lifesciences Corporation
